A
Anbio Biotechnology
Biotechnology: In Vitro & In Vivo Diagnostic Substances company
Key Metrics of Anbio Biotechnology
Revenue$6.7M▼ 71.5% YoYFY 2023
Operating income$2.0M▼ 80.8% YoY
Net profit$2.3M▼ 77.5% YoY
Shareholders' equity$14.8M
Market cap$553MNNNN · $3.84
Competitors10identified
About Anbio Biotechnology
Sectors
Company details
- Founded
- 2025
- Listed
- Nasdaq: NNNN (since 2025)
Operational Areas of Anbio Biotechnology
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameAnbio Biotechnology
TickerNNNN
ExchangeNasdaq
CountryGermany
SEC CIK0001982708
Listed since2025
IndustryBiotechnology: In Vitro & In Vivo Diagnostic Substances
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Website—
US market & SEC filings
NNNN · Nasdaq · SEC CIK 0001982708
Last price · 29 Oct 2026
$3.84
+3.50%
Market cap$553M
P/E36.6On FY 2023 diluted EPS
Volume35,202
SectorHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances
Country · IPOGermanyListed 2025
NNNN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Anbio Biotechnology
Competitors10identified
Countries1most in Germany
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | the-odin.com | — | Solan, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | morphosys.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | curevac.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | medigene.com | — | Jaipur, Germany | |
 Evotec |
Biotechnology & Vaccines · Pharmaceuticals & Healthcare | evotec.com | 1993 | Germany |
| Part of GSK. | glaxosmithkline.de | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | miltenyibiotec.com | — | Hyderabad, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | mwg-biotech.com | — | Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | promega.com | — | Mumbai, Germany | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | gatc-biotech.com | — | Germany |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.